CASE REPORT
Accepted on 16 Jun 2025
Long-term survival in advanced pulmonary large-cell neuroendocrine carcinoma after multi-line immunochemotherapy and anti-angiogenic therapy: a case report
doi 10.3389/fimmu.2025.1618672
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- The Application of Immune Checkpoint Inhibitors Combined with Chemotherapy in Tumor Immunotherapy
The Application of Immune Checkpoint Inhibitors Combined with Chemotherapy in Tumor Immunotherapy
3,976
Total downloads
18k
Total views and downloads
Articles
CASE REPORT
Accepted on 09 Jun 2025
Durable Immunotherapeutic Response in Molecularly Complex Pulmonary Adenosquamous Carcinoma: case report and literature review
doi 10.3389/fimmu.2025.1614283
- 113 views
CASE REPORT
Accepted on 09 Jun 2025
Cadonilimab Combined with Trastuzumab and Chemotherapy for HER2-Positive Gastric Cancer with Bone Marrow Metastasis and DIC: A Case Report and Literature Review
doi 10.3389/fimmu.2025.1608636
- 140 views
ORIGINAL RESEARCH
Accepted on 02 Jun 2025
Total neoadjuvant immunochemotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer
doi 10.3389/fimmu.2025.1611386
- 209 views
ORIGINAL RESEARCH
Published on 20 May 2025
B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer
doi 10.3389/fimmu.2025.1553042
- 1,082 views
CASE REPORT
Published on 01 May 2025
Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemotherapy followed by radiotherapy with maintenance therapy: a case report
doi 10.3389/fimmu.2025.1573202
- 1,247 views
ORIGINAL RESEARCH
Published on 28 Apr 2025
The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study
doi 10.3389/fimmu.2025.1579420
- 908 views
ORIGINAL RESEARCH
Published on 14 Apr 2025
Comparison of immunotherapy based total neoadjuvant therapy or standard neoadjuvant chemoradiation for locally advanced rectal cancer: a multi-institutional retrospective study
doi 10.3389/fimmu.2025.1513716
- 940 views
REVIEW
Published on 08 Apr 2025
Efficacy and safety of programmed cell death protein-1 inhibitor for first-line therapy of advanced gastric or gastroesophageal junction cancer: a network meta-analysis
doi 10.3389/fimmu.2025.1500954
- 1,465 views
ORIGINAL RESEARCH
Published on 27 Mar 2025
Neoadjuvant immunotherapy for NSCLC: superior combination strategies, optimal treatment cycles, and predictive indicators from a Bayesian meta-analysis
doi 10.3389/fimmu.2025.1548665
- 1,817 views
ORIGINAL RESEARCH
Accepted on 17 Mar 2025
Efficacy and safety of Geptanolimab in previously treated PD-L1-Positive recurrent or metastatic cervical cancer: a multi-center openlabel, single-arm, phase Ⅱ study
doi 10.3389/fonc.2025.1528276
- 174 views
CASE REPORT
Published on 10 Mar 2025
Case Report: Metastatic succinate dehydrogenase–deficient gastrointestinal stromal tumor treated with chemotherapy and immune checkpoint inhibitor
doi 10.3389/fonc.2025.1549232
- 1,202 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore